Treatment of patients with advanced colorectal cancer with cisplatin, 5-fluorouracil, and leucovorin
Data up to Jan 2025
Total Citations Per Year
Abstract
References (30)
Nonparametric Estimation from Incomplete Observations
1992 • 45,923 citations
Nonparametric Estimation from Incomplete Observations
1958 • 37,219 citations
Toxicity and response criteria of the Eastern Cooperative Oncology Group
1982 • 10,605 citations
Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.
1989 • 911 citations
A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.
1988 • 513 citations
A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.
1987 • 452 citations
Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil.
1981 • 287 citations
Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer
1989 • 220 citations
A phase III trial of 5-fluorouracil and leucovorin in the treatment of advanced colorectal cancer. A mayo clinic/north central cancer treatment group study
1989 • 209 citations
Cytotoxicity of 5-fluoro-2'-deoxyuridine: requirement for reduced folate cofactors and antagonism by methotrexate.
1978 • 196 citations
Biochemical determinants of responsiveness to 5-fluorouracil and its derivatives in xenografts of human colorectal adenocarcinomas in mice.
1981 • 195 citations
A phase III study comparing the clinical utility of four regimens of 5-Fluorouracil.A preliminary report
1977 • 150 citations
Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for locally advanced head and neck cancer: a clinical and pharmacologic analysis.
1990 • 106 citations
Chemotherapy of large bowel cancer.
1982 • 104 citations
Basis for natural variation in sensitivity to 5-fluorouracil in mouse and human cells in culture.
1979 • 104 citations
No benefit of ifosfamide in Ewing's sarcoma: a nonrandomized study of the French Society of Pediatric Oncology.
1992 • 101 citations
The enhancement of 5-fluorouracil antimetabolic activity by leucovorin, menadione and α-tocopherol
1982 • 91 citations
Approximate Confidence Intervals for Probabilities of Survival and Quantiles in Life-Table Analysis
1982 • 82 citations
Levamisole as an adjuvant to chemotherapy in extensive bronchogenic carcinoma. A veterans administration lung cancer group study
1982 • 70 citations
A phase II trial of 5-fluorouracil and high-dose intravenous leucovorin in gastric carcinoma.
1987 • 61 citations
A randomized study of inpatient versus outpatient continuous infusion chemotherapy for patients with locally advanced head and neck cancer
1989 • 45 citations
Cisplatin, 5‐fluorouracil, and high‐dose oral leucovorin for advanced head and neck cancer
1989 • 32 citations
The Expanding Role of Folates and Fluoropyrimidines in Cancer Chemotherapy
1988 • 31 citations
5-FU/leucovorin: biochemical modulation that works?
1987 • 28 citations
Cisplatin, 5-fluorouracil, and high-dose oral leucovorin for advanced head and neck cancer
1989 • 20 citations
A study of various strategies to enhance the cytotoxic activity of 5-fluorouracil/leucovorin in human colorectal cancer cell lines.
1989 • 10 citations
Progress Report on Studies of FAM-CF for Gastric Cancer and Intraperitoneal Administration of FUra-CF Followed by Cisplatin (DDP)
1988 • 6 citations
Phase I clinical trial of cisplatin given i.v. with 5-fluorouracil and high-dose folinic acid
1990 • 5 citations
Phase II Evaluation of 5-Fluorouracil, Folinic Acid and Cisplatin in Advanced-Stage Colorectal Adenocarcinoma
1989 • 5 citations
Phase I Trial of Semustine Plus Weekly Fluorouracil and High-Dose Leucovorin Calcium in Patients With Advanced Colorectal Cancer
1989 • 2 citations